We are happy to announce that the the Hôpital Bicêtre AP-HP in Le Kremlin- Bicêtre in France enrolled the first study participant on May 2, 2025. Congratulation to the study team!
We are happy to announce that the second site in Belgium is open for recruitment. We wish the trial team good luck!
We are happy to announce that the CHU Brest in France enrolled the first study participant on January 22, 2025. Congratulation to the study team!
We are happy to inform you that the Cliniques Universitaires Saint-Luc CUSL in Brussels started with patient screening/enrollment on 2nd October. We wish the trial team at CUSL good luck!
We are happy to announce that the CHU de Lyon in France enrolled the first study participant on 14th of June 2024. Congratulation to the study team!
We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
We wish the study team good luck!
We are happy to announce that the Ottawa Hospital in Canada enrolled the first study participant on 8th of November 2023. Congratulation to the study team!
We are happy to inform you that the first site in France, the Hôpital de la Cavale Blanche (CHU) is open for accrual since Agust 30 2023. We wish the study team in Brest good luck for patient enrollment!
We are pleased to inform you that the first trial participant was enrolled at the Cantonal Hospital in Liestal (CH) on 17th of June 2023. Thank you for your great effort!
Prof. Dr. med. Drahomir Aujesky
Klinikdirektor und Chefarzt Allgemeine Innere Medizin
Universitätsspital Inselspital
safe-sspe@insel.ch